Skip to main content
. 2020 Sep 15;11:561306. doi: 10.3389/fphar.2020.561306

Figure 6.

Figure 6

Ubc9 increases the SUMOylation of Beclin1 under OGD treatment Adv-Ubc9 was transfected in NRCMs for 48 h, then maintained in hypoxic condition for 6 h. (A, B) Endogenous SUMOylation of Vps34 and Beclin1 in NRCMs. Beclin1 or Vps34 was IP, and followed by IB for SUMO-1 or SUMO-2/3.